Perceptive Advisors LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $3.83 Billion distributed in 108 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Arcellx, Inc. with a value of $325M, Nuvalent, Inc. with a value of $305M, Amicus Therapeutics, Inc. with a value of $300M, Iovance Biotherapeutics, Inc. with a value of $250M, and Vaxcyte, Inc. with a value of $231M.
Examining the 13F form we can see an increase of $371M in the current position value, from $3.46B to 3.83B.
Perceptive Advisors LLC is based out at New York, NY
Below you can find more details about Perceptive Advisors LLC portfolio as well as his latest detailed transactions.
